Vestcor Inc’s Cellebrite CLBT Stock Holding History

Vestcor Inc’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,783	Closed	-$68K	–	1214
2025 Q4	$68K	Hold	3,783	–	–	﹤0.01%	1091
2025 Q3	$70K	Buy	+3,783	New	+$59.4K	﹤0.01%	1111

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vestcor Inc's CLBT Position: Q1 2026 in Review

Vestcor Inc sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 3,783 shares — an estimated $68K sold.

Vestcor Inc first reported a position in CLBT in Q3 2025 and held it in 2 quarters. The position peaked at $70K in Q3 2025. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

Vestcor Inc reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
Vestcor Inc sold 3,783 Cellebrite shares in Q1 2026, an estimated $68K.
Vestcor Inc first reported a position in Cellebrite in Q3 2025 and held it in 2 quarters.
Vestcor Inc's Cellebrite position peaked at $70K in Q3 2025.
221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.